clinical trial · NCT06883123
Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost
Prairie Eye Center·phase4·recruiting·n = 70
Open Angle GlaucomaSimbrinza 0.2%-1% Ophthalmic SuspensionRocklatan 0.02%-0.005% Ophthalmic SolutionCosopt PF 2%-0.5% Ophthalmic SolutionLatanoprost 0.005% Ophthalmic Solution
brief summary
A randomized, multi-site, parallel-group, prospective study of patients who are adults with a diagnosis of mild to moderate open-angle glaucoma (OAG), currently on an on-label use of combination topical medication of Cosopt and Latanoprost for a minimum of 1 month.
started
May 14, 2025
primary completion
Apr 1, 2026
completion
Apr 1, 2026
last updated
May 15, 2025
official title
Efficacy and Tolerability of Simbrinza and Rocklatan vs. Cosopt
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol